Significance of spread through air spaces in early-stage lung adenocarcinomas undergoing limited resection
- PMID: 30079987
- PMCID: PMC6166074
- DOI: 10.1111/1759-7714.12828
Significance of spread through air spaces in early-stage lung adenocarcinomas undergoing limited resection
Abstract
Background: In early-stage lung adenocarcinomas, spread through air spaces (STAS) are reported to be a prognostic factor in patients who have undergone sublobar resection, but not lobectomy. In contrast, reports have also shown that STAS is significantly associated with poor survival outcomes after lobectomy, but not after limited resection. Thus, the prognostic impact of STAS differs according to published reports.
Methods: A total of 82 patients with early-stage adenocarcinomas who underwent limited resection and whose STAS status could be examined were enrolled in this retrospective study. We evaluated the association between STAS and clinicopathological characteristics and postoperative survival.
Results: Among 82 patients, 31 (37.8%) were positive for STAS, while 51 (62.2%) were negative. STAS was significantly associated with advanced tumor stage (P < 0.01), lower histological differentiation (P = 0.01), and the presence of pleural invasion (P = 0.01). Patients with STAS had significantly shorter recurrence-free survival (RFS) and overall survival (OS) than those without STAS (P < 0.01 and P = 0.02, respectively). According to multivariate analysis, positivity for STAS was an independent prognostic parameter for RFS (P < 0.01), but not OS (P = 0.45). Three patients who developed surgical margin recurrence and one patient who developed distant recurrence were all positive for STAS.
Conclusions: STAS was predictive of poor postoperative survival in patients with early-stage adenocarcinomas treated with limited resection and was associated with surgical margin recurrence.
Keywords: Early-stage; limited resection; lung adenocarcinoma; spread through air spaces; surgical margin recurrence.
© 2018 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
Figures
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5–29. - PubMed
-
- Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non‐small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995; 60: 615–22. - PubMed
-
- Suzuki K, Watanabe S, Wakabayashi M et al A nonrandomized confirmatory phase III study of sublobar surgical resection for peripheral ground glass opacity dominant lung cancer defined with thoracic thin‐section computed tomography (JCOG0804/WJOG4507L). J Clin Oncol 2017; 35 (15 Suppl): Abstract 8561.
-
- Aokage K, Yoshida J, Hishida T et al Limited resection for early‐stage non‐small cell lung cancer as function‐preserving radical surgery: A review. Jpn J Clin Oncol 2017; 47: 7–11. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
STAS− (n = 51),
STAS+ (n = 31).